Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Apr 1998

Zinzani P L, Pileri S, Bendandi M, Buzzi M, Sabattini E, Ascani S, Gherlinzoni F, Magagnoli M, Albertini P, Tura S

Abstract excerpt

PURPOSE: In the last few years, the search for new biologic markers in high-grade non-Hodgkin's lymphomas has provided important results. In particular, soluble CD30 (sCD30) levels were elevated in most patients with Hodgkin's disease (HD) and anaplastic large-cell lymphoma (ALCL). PATIENTS AND METHODS: From September 1988 to October 1993, treatment was completed in 70 previously untreated patients with ALCL, of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cyclophosphamide

Share to Doxorubicin

Share to Lymphoma, Large B-Cell, Diffuse

Share to Lymphoma, Non-Hodgkin

Share to Methotrexate

Share to Phenotype

Source

Identifiers

PMID: 9552063
DOI: 10.1200/JCO.1998.16.4.1532

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.PMID 9552063Read ↗

Anaplastic large-cell lymphoma: clinical and prognostic evaluation of 90 adult patients.Semantic proximity Read ↗

Anaplastic large cell lymphoma: a clinicopathologic study of 53 patients.Semantic proximity Read ↗

CD30 in Normal and Neoplastic CellsSemantic proximity Read ↗

[Adult's anaplastic CD30+ large cell lymphomas].Semantic proximity Read ↗

Primary systemic anaplastic large-cell lymphoma (CD30+): advances in biology and current therapeutic approaches.Semantic proximity Read ↗

CD30 expression in acute lymphoblastic leukemia as assessed by flow cytometry analysis.Semantic proximity Read ↗

Mechanism of action and therapeutic targeting of CD30 molecule in lymphomasSemantic proximity Read ↗

A CD30-positive T cell line established from an aggressive anaplastic large cell lymphoma, originally diagnosed as Hodgkin's disease.Semantic proximity Read ↗

High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin diseaseSemantic proximity Read ↗

Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma.Semantic proximity Read ↗

Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma.Semantic proximity Read ↗

Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.